// App-Quantinova.ai

: High compliance to prophylaxis regimens in adult and paediatric hemophilia B patients receiving RIX‐FP in clinical studies

Researchers

Presenter

  • C. Altisent

Principal Investigators

  • G. Kenet

  • J. Oldenburg

  • A. Chan

  • L. Boggio

  • W. Seifert

  • E. Santagostino

Medical Centers

  • Haemophilia Unit. BST-Hospital Universitari Vall -Hebron, Barcelona, Spain

  • The Israeli National Hemophilia Center, Sheba Medical Center, Tel Hashomer, Sackler Medical School, Tel Aviv University, Tel Aviv, Israel

  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

  • Rush Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago, IL

  • CSL Behring, Marburg, Germany

  • Angelo Bianchi Bonomi Haemophilia andThrombosis Center. IRCCS Ca Granda Foundation,Maggiore Hospital, Milan, Italy

Locations

  • Spain

  • Israel

  • Germany

  • Canada

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Baxter International and CSL Behring

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved